Nolpaza (Pantoprazole)

Pantoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

• Gastro‑oesophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation.
• Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.
• NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

• Pantoprazole is a benzimidazole‑derived proton pump inhibitor that binds covalently to the sulfhydryl group of the H⁺/K⁺‑ATPase enzyme located on gastric parietal cells. This irreversible inhibition blocks the final step of acid secretion, leading to a sustained reduction in gastric acidity for up to 24 hours after a single dose. The effect is dose‑dependent and persists until new enzyme molecules are synthesized, providing prolonged acid control.

Pantoprazole may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: mild to moderate pain in the head.
• Diarrhea: loose, watery stools.
• Nausea: feeling of sickness.
• Abdominal pain: discomfort in the stomach area.
• Flatulence: increased intestinal gas.
• Constipation: difficulty passing stools.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with breathing difficulty.
• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Hypomagnesemia: low blood magnesium levels, may cause muscle cramps.
• Elevated liver enzymes: signs of hepatic stress.
• Stevens‑Johnson syndrome: rare skin and mucous membrane disorder.
• Bone fracture risk: long‑term use may reduce bone mineral density.

When prescribing Pantoprazole, clinicians should consider several safety precautions to minimize risks.

• Assess renal function: adjust therapy in patients with severe impairment.
• Monitor for infection: be vigilant for signs of Clostridioides difficile colitis.
• Check magnesium levels: prolonged treatment can lead to hypomagnesemia.
• Avoid abrupt discontinuation: sudden stop may cause rebound acid hypersecretion.
• Pregnancy and lactation: use only if potential benefit justifies potential risk.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Pantoprazole can alter the pharmacokinetics of several co‑administered medicines; awareness of key interactions helps optimize therapy.

Major Interactions (Avoid)

• Ketoconazole: reduced absorption and efficacy.
• Atazanavir: markedly decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet activity.
• Warfarin: possible increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely)

• Digoxin: increased serum levels may occur.
• Methotrexate: reduced renal clearance leading to higher exposure.
• Iron salts: decreased iron absorption when taken simultaneously.